NCT01413178
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Paraproteinemias
Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.
3,008 public trials
572 recruiting studies
Paraproteinemias trial results
NCT01212952
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT01497093
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +13 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
- Memorial Sloan Kettering Westchester Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT01087008
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hospital Universitari Germans Trias I Pujol Badalona, Spain
- Hospital de la Santa Creu i Sant Pau Barcelona, Spain
- Hospital del Mar Barcelona, Spain
- Hospital Vall d'Hebrón Barcelona, Spain
NCT00003687
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
- McGill University Montreal, Quebec, Canada
NCT00006890
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- St. Mary's/Duluth Clinic Health System Duluth, Minnesota, United States
- Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
- Lethbridge Cancer Clinic Lethbridge, Alberta, Canada
- Burnaby Hospital Regional Cancer Centre Burnaby, British Columbia, Canada
NCT00002678
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- St. Mary's/Duluth Clinic Health System Duluth, Minnesota, United States
- Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
- Cross Cancer Institute Edmonton, Alberta, Canada
- British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
NCT00031668
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +30 more
- Locations
-
- Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
- Cross Cancer Institute Edmonton, Alberta, Canada
- Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
- Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada
Completed
Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis
NCT01318902
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
- Locations
-
- Tufts Medical Center Boston, Massachusetts, United States
- Boston Medical Center Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Mayo Clinic Rochester, Minnesota, United States